voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
Voglidac, Voglibose 0.2 mg MD, Voglibose, Voglidac 0,2, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
Voglidac, Voglibose 0.2 mg MD, Voglibose, Voglidac 0,2, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine
voglidac, voglidac 02, voglidac 03, voglidac mf, daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine

VOGLIDAC

TAB VOGLIDAC 0.2 (Voglibose 0.2 mg MD) ALU-ALU 10 X 10
TAB VOGLIDAC 0.3 (Voglibose 0.3 mg MD ) ALU-ALU 10 X 10
TAB VOGLIDAC 0.2 MF (Voglibose 0.2 mg + Metformin 500 mg ) ALU-ALU 10 X 10
TAB VOGLIDAC 0.3 MF (Voglibose 0.3 mg + Metformin 500 mg ) ALU-ALU 10 X 10
Category: Tag:
Send Enquiry
Introduction:

VOGLIDAC is a prescription medication containing Voglibose 0.3 mg, an alpha-glucosidase inhibitor. It is primarily used to manage postprandial (after-meal) blood glucose levels in individuals with type 2 diabetes mellitus. By delaying the absorption of carbohydrates in the intestines, VOGLIDAC helps prevent sudden spikes in blood sugar levels following meals.

Indications:

VOGLIDAC is indicated for:

  • Type 2 Diabetes Mellitus: As an adjunct to diet and exercise to improve glycemic control.

  • Postprandial Hyperglycemia: To reduce elevated blood sugar levels after meals.

It is often prescribed when other antidiabetic medications do not provide adequate control.

Dosage and Administration:

Adults:

  • Recommended Dose: 0.2 mg to 0.3 mg taken orally three times daily, just before each main meal.

Administration Tips:

  • Take VOGLIDAC immediately before meals to maximize its effectiveness.

  • Swallow the tablet whole with water; do not crush or chew.

  • Maintain a consistent schedule by taking the tablet at the same times each day.

  • Adhere to the prescribed dosage and duration as directed by your healthcare provider.

Precautions and Warnings:

Before initiating VOGLIDAC, inform your healthcare provider if you have:

  • Gastrointestinal Disorders: Such as inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction.

  • Liver or Kidney Impairment: Use with caution; dose adjustments may be necessary.

  • Pregnancy and Lactation: Consult your doctor before use.

Contraindications:

  • Known hypersensitivity to Voglibose or any component of the tablet.

Drug Interactions:

  • May interact with other antidiabetic medications, potentially leading to hypoglycemia.

  • Inform your doctor about all medications you are taking to avoid potential interactions.

Potential Side Effects:

Common Side Effects:

  • Flatulence (gas)

  • Abdominal discomfort or pain

  • Diarrhea

  • Nausea

Serious Side Effects:

  • Liver dysfunction (elevated liver enzymes)

  • Severe gastrointestinal symptoms

If any serious side effects occur, discontinue use and seek immediate medical attention.

Product Range & Benefits:
VOGLIDAC

Composition: Voglibose 0.3 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: VOGLIDAC is indicated for the management of postprandial blood glucose levels in individuals with type 2 diabetes mellitus.

Key Benefits:

  • Effectively reduces post-meal blood sugar spikes.

  • Complements other antidiabetic therapies for improved glycemic control.

  • Convenient dosing schedule enhances patient compliance.

  • Minimal risk of hypoglycemia when used as monotherapy.

Conclusion:

VOGLIDAC Voglibose 0.3 mg Tablet offers a targeted approach to managing postprandial hyperglycemia in type 2 diabetes. By inhibiting carbohydrate absorption in the intestines, it helps maintain stable blood sugar levels after meals. Always consult your healthcare provider before starting any new medication.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Diabetic

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products